Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36156125)

  • 21. ANGPTL1 is a potential biomarker for differentiated thyroid cancer diagnosis and recurrence.
    Sun R; Yang L; Hu Y; Wang Y; Zhang Q; Zhang Y; Ji Z; Zhao D
    Oncol Lett; 2020 Nov; 20(5):240. PubMed ID: 32973954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
    Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
    Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
    Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
    Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of miR-223 on colorectal cancer cell proliferation and apoptosis through regulating FoxO3a/BIM.
    Ju H; Tan JY; Cao B; Song MQ; Tian ZB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3771-3778. PubMed ID: 29949152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA ANGPTL1-3 promotes multiple myeloma bortezomib resistance by sponging miR-30a-3p to activate c-Maf expression.
    Nian F; Zhu J; Chang H
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1140-1146. PubMed ID: 31103265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA
    Zhao X; Wu J; Li Y; Ye F; Wang C
    Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population.
    Kasashima H; Duran A; Martinez-Ordoñez A; Nakanishi Y; Kinoshita H; Linares JF; Reina-Campos M; Kudo Y; L'Hermitte A; Yashiro M; Ohira M; Bao F; Tauriello DVF; Batlle E; Diaz-Meco MT; Moscat J
    Dev Cell; 2021 Jan; 56(1):95-110.e10. PubMed ID: 33207226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNAs lnc-ANGPTL1-3:3 and lnc-GJA10-12:1 present as regulators of sentinel lymph node metastasis in breast cancer.
    Sun D; Zhong J; Wei W; Liu L; Liu J; Lin X
    Oncol Lett; 2020 Nov; 20(5):188. PubMed ID: 32952657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.
    Lundberg IV; Löfgren Burström A; Edin S; Eklöf V; Öberg Å; Stenling R; Palmqvist R; Wikberg ML
    PLoS One; 2014; 9(7):e101957. PubMed ID: 25010701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
    Yang N; Wang Y; Hui L; Li X; Jiang X
    J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
    Han YT; Chen XH; Gao H; Ye JL; Wang CB
    Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Clinical Impact and Biological Function of Angiopoietin and Angiopoietin-like Proteins in Human Breast Cancer.
    Yang H; Zhang M; Mao XY; Chang H; Perez-Losada J; Mao JH
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.
    Chen J; Chen S; Zhuo L; Zhu Y; Zheng H
    Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
    Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
    J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
    Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
    J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 37. A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6.
    Marchiò S; Soster M; Cardaci S; Muratore A; Bartolini A; Barone V; Ribero D; Monti M; Bovino P; Sun J; Giavazzi R; Asioli S; Cassoni P; Capussotti L; Pucci P; Bugatti A; Rusnati M; Pasqualini R; Arap W; Bussolino F
    EMBO Mol Med; 2012 Nov; 4(11):1156-75. PubMed ID: 23070965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA LOC100507144 acts as a novel regulator of CD44/Nanog/Sox2/miR-302/miR-21 axis in colorectal cancer.
    Ebrahimi N; Rezanejad H; Asadi MH; Vallian S
    Biofactors; 2022 Jan; 48(1):164-180. PubMed ID: 34882869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alanine-Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells.
    Ye P; Chi X; Yan X; Wu F; Liang Z; Yang WH
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.
    Russo MV; Esposito S; Tupone MG; Manzoli L; Airoldi I; Pompa P; Cindolo L; Schips L; Sorrentino C; Di Carlo E
    Oncotarget; 2016 Mar; 7(11):12372-85. PubMed ID: 26540632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.